Patent 9233956 was granted and assigned to Novartis on January, 2016 by the United States Patent and Trademark Office.
The present invention provides thiazole sulfonamide and oxazole sulfonamide compounds, compositions containing the same, as well as processes for the preparation and methods for their use as pharmaceutical agents.